UA76411C2 - Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation - Google Patents
Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation Download PDFInfo
- Publication number
- UA76411C2 UA76411C2 UA2002076286A UA2002076286A UA76411C2 UA 76411 C2 UA76411 C2 UA 76411C2 UA 2002076286 A UA2002076286 A UA 2002076286A UA 2002076286 A UA2002076286 A UA 2002076286A UA 76411 C2 UA76411 C2 UA 76411C2
- Authority
- UA
- Ukraine
- Prior art keywords
- mixture
- mass
- pharmaceutical composition
- amount
- agglomerate
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract description 27
- 239000008194 pharmaceutical composition Substances 0.000 title abstract description 13
- 238000002360 preparation method Methods 0.000 title abstract description 6
- PPKXEPBICJTCRU-XMZRARIVSA-N (R,R)-tramadol hydrochloride Chemical compound Cl.COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 PPKXEPBICJTCRU-XMZRARIVSA-N 0.000 title abstract description 4
- 238000013270 controlled release Methods 0.000 title abstract description 4
- 229960003107 tramadol hydrochloride Drugs 0.000 title abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 49
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 36
- 239000004480 active ingredient Substances 0.000 abstract description 15
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 14
- 239000000194 fatty acid Substances 0.000 abstract description 14
- 229930195729 fatty acid Natural products 0.000 abstract description 14
- 150000004665 fatty acids Chemical class 0.000 abstract description 14
- 150000002148 esters Chemical class 0.000 abstract description 11
- 150000003839 salts Chemical class 0.000 abstract description 10
- 229920000642 polymer Polymers 0.000 abstract description 9
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract description 8
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract description 4
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Chemical class [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052814 silicon oxide Inorganic materials 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract description 3
- 150000001342 alkaline earth metals Chemical class 0.000 abstract description 3
- 150000001447 alkali salts Chemical class 0.000 abstract 1
- 239000002245 particle Substances 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 235000011187 glycerol Nutrition 0.000 description 13
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 229940075614 colloidal silicon dioxide Drugs 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 7
- -1 glycerol ester Chemical class 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 6
- 235000021357 Behenic acid Nutrition 0.000 description 5
- 229940116226 behenic acid Drugs 0.000 description 5
- KFEVDPWXEVUUMW-UHFFFAOYSA-N docosanoic acid Natural products CCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 KFEVDPWXEVUUMW-UHFFFAOYSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229960004380 tramadol Drugs 0.000 description 4
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- RBNPOMFGQQGHHO-UHFFFAOYSA-N glyceric acid Chemical compound OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 150000004683 dihydrates Chemical class 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229940126601 medicinal product Drugs 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229910000287 alkaline earth metal oxide Inorganic materials 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000004035 chlorins Chemical class 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- HOWGUJZVBDQJKV-UHFFFAOYSA-N docosane Chemical compound CCCCCCCCCCCCCCCCCCCCCC HOWGUJZVBDQJKV-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical class [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 239000012052 hydrophilic carrier Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 239000008238 pharmaceutical water Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SK1868-99A SK285128B6 (sk) | 1999-12-28 | 1999-12-28 | Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy |
| PCT/SK2000/000027 WO2001047497A2 (en) | 1999-12-28 | 2000-12-20 | Controlled release pharmaceutical composition containing tramadol hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA76411C2 true UA76411C2 (en) | 2006-08-15 |
Family
ID=20434830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2002076286A UA76411C2 (en) | 1999-12-28 | 2000-12-20 | Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20030175343A1 (cs) |
| EP (1) | EP1255535B1 (cs) |
| JP (1) | JP2003518486A (cs) |
| AT (1) | ATE324103T1 (cs) |
| AU (1) | AU2421601A (cs) |
| BG (1) | BG65713B1 (cs) |
| CA (1) | CA2397942C (cs) |
| CY (1) | CY1106127T1 (cs) |
| CZ (1) | CZ297394B6 (cs) |
| DE (1) | DE60027601T2 (cs) |
| DK (1) | DK1255535T3 (cs) |
| EA (1) | EA006438B1 (cs) |
| EE (1) | EE05231B1 (cs) |
| ES (1) | ES2266018T3 (cs) |
| GE (1) | GEP20053532B (cs) |
| HU (1) | HUP0203842A3 (cs) |
| LT (1) | LT5033B (cs) |
| LV (1) | LV12917B (cs) |
| PL (1) | PL208096B1 (cs) |
| PT (1) | PT1255535E (cs) |
| SI (1) | SI1255535T1 (cs) |
| SK (1) | SK285128B6 (cs) |
| TW (1) | TWI221419B (cs) |
| UA (1) | UA76411C2 (cs) |
| WO (1) | WO2001047497A2 (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8128957B1 (en) | 2002-02-21 | 2012-03-06 | Valeant International (Barbados) Srl | Modified release compositions of at least one form of tramadol |
| US20050182056A9 (en) * | 2002-02-21 | 2005-08-18 | Seth Pawan | Modified release formulations of at least one form of tramadol |
| SK286107B6 (sk) * | 2002-04-12 | 2008-03-05 | Zentiva, A. S. | Analgeticky účinný perorálny liečivý prípravok s kontrolovaným uvoľňovaním opioidnej účinnej látky a spôsob jeho prípravy |
| DE10245623A1 (de) * | 2002-09-30 | 2004-04-08 | Clariant Gmbh | Ester und Partialester aus mehrwertigen Alkoholen |
| PL1651248T3 (pl) * | 2003-07-11 | 2010-02-26 | Novartis Ag | Doustnie dawkowana kompozycja farmaceutyczna zawierająca środek dostarczający w postaci mikronizowanej |
| US20080274264A1 (en) * | 2006-06-09 | 2008-11-06 | John Godber | Calcium fortification substance for clear beverages |
| US20100143573A1 (en) * | 2006-06-09 | 2010-06-10 | John Godber | Mineral fortification substance for clear beverages |
| DE102006044694A1 (de) * | 2006-09-22 | 2008-03-27 | Krewel Meuselbach Gmbh | Perorale feste Schmerzmittelzubereitung |
| US20100003322A1 (en) * | 2008-07-03 | 2010-01-07 | Lai Felix S | Enteric coated hydrophobic matrix formulation |
| HUE051406T2 (hu) | 2012-11-14 | 2021-03-01 | Grace W R & Co | Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL109460A (en) | 1993-05-10 | 1998-03-10 | Euro Celtique Sa | Controlled release formulation comprising tramadol |
| DE4329794C2 (de) * | 1993-09-03 | 1997-09-18 | Gruenenthal Gmbh | Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung |
| EP0654263B1 (en) | 1993-11-23 | 2002-01-23 | Euro-Celtique S.A. | Method for preparing a sustained release composition |
| DE4343993A1 (de) * | 1993-12-22 | 1995-06-29 | Stockhausen Chem Fab Gmbh | Pfropf-Copolymerisate von ungesättigten Monomeren und Polyhydroxyverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung |
| FR2753904B1 (fr) * | 1996-10-01 | 1998-10-30 | Gattefosse Ets Sa | Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication |
| US5980941A (en) * | 1997-08-20 | 1999-11-09 | Fuisz Technologies Ltd. | Self-binding shearform compositions |
| DE19901683B4 (de) * | 1999-01-18 | 2005-07-21 | Grünenthal GmbH | Analgetikum mit kontrollierter Wirkstofffreisetzung |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
-
1999
- 1999-12-28 SK SK1868-99A patent/SK285128B6/sk not_active IP Right Cessation
-
2000
- 2000-11-28 TW TW089125229A patent/TWI221419B/zh not_active IP Right Cessation
- 2000-12-20 UA UA2002076286A patent/UA76411C2/uk unknown
- 2000-12-20 US US10/168,967 patent/US20030175343A1/en not_active Abandoned
- 2000-12-20 AU AU24216/01A patent/AU2421601A/en not_active Abandoned
- 2000-12-20 DE DE60027601T patent/DE60027601T2/de not_active Expired - Fee Related
- 2000-12-20 EA EA200200720A patent/EA006438B1/ru not_active IP Right Cessation
- 2000-12-20 JP JP2001548092A patent/JP2003518486A/ja active Pending
- 2000-12-20 EE EEP200200368A patent/EE05231B1/xx unknown
- 2000-12-20 PL PL357680A patent/PL208096B1/pl unknown
- 2000-12-20 WO PCT/SK2000/000027 patent/WO2001047497A2/en active IP Right Grant
- 2000-12-20 AT AT00987947T patent/ATE324103T1/de not_active IP Right Cessation
- 2000-12-20 HU HU0203842A patent/HUP0203842A3/hu unknown
- 2000-12-20 SI SI200030873T patent/SI1255535T1/sl unknown
- 2000-12-20 CZ CZ20022371A patent/CZ297394B6/cs not_active IP Right Cessation
- 2000-12-20 EP EP00987947A patent/EP1255535B1/en not_active Expired - Lifetime
- 2000-12-20 PT PT00987947T patent/PT1255535E/pt unknown
- 2000-12-20 ES ES00987947T patent/ES2266018T3/es not_active Expired - Lifetime
- 2000-12-20 DK DK00987947T patent/DK1255535T3/da active
- 2000-12-20 GE GE4852A patent/GEP20053532B/en unknown
- 2000-12-20 CA CA002397942A patent/CA2397942C/en not_active Expired - Lifetime
-
2002
- 2002-07-02 LT LT2002078A patent/LT5033B/lt not_active IP Right Cessation
- 2002-07-25 BG BG106952A patent/BG65713B1/bg unknown
- 2002-07-26 LV LVP-02-137A patent/LV12917B/en unknown
-
2006
- 2006-07-26 CY CY20061101035T patent/CY1106127T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3279998A (en) | Method of preparing sustained release tablets | |
| US5104648A (en) | High ibuprofen content granulations | |
| JPH09509176A (ja) | 微粒子医薬調合物の調製プロセス | |
| US5453283A (en) | Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation | |
| JPS6140204B2 (cs) | ||
| US4911921A (en) | High ibuprofen content granulations | |
| UA76411C2 (en) | Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation | |
| SK13252002A3 (sk) | Farmaceutické prípravky | |
| JP2003528829A6 (ja) | 薬剤学的製剤 | |
| EP1083196B1 (de) | Unterwassergranulation wirkstoffhaltiger Schmelzen | |
| JPS58214333A (ja) | 粒状物 | |
| JPS5989634A (ja) | 遅れて作用物質を放出する固形のプレスされた薬物配合物及びその製造方法 | |
| CZ303694B6 (cs) | Prípravek nesteroidního protizánetlivého léciva obsahující granulární a extragranulární kompozici a zpusob jeho prípravy | |
| JP2006517929A (ja) | 溶融アグロメレーションを用いてアグロメレートを製造する方法 | |
| WO2010081815A1 (en) | Aqueous coacervate composition comprising poorly water-soluble biologically-active agents | |
| JPH03161448A (ja) | 油脂含有組成物 | |
| JPH11243907A (ja) | 錠剤の製造方法 | |
| Bertuzzi | Effervescent granulation | |
| Us et al. | Melt granulation: an alternative to traditional granulation techniques | |
| Timaniya et al. | MELT GRANULATION: A CRITICAL REVIEW ON FORMULATION APPROACHES. | |
| JP2021063013A (ja) | 経口固形製剤の製造方法 | |
| EA006846B1 (ru) | Болеутоляющая композиция для перорального применения с регулируемым высвобождением опиоида | |
| EP2407156A2 (en) | Aqueous coacervate compositions suitable for making powders and water-soluble formulations of biologically-active agents | |
| HU191102B (en) | Process for producing pharmaceutical compositions of regulated dissolution of the active agents containing water-soluble inorganic pharmacons | |
| DE10010509A1 (de) | Pharmazeutische Formulierungen |